Arca Biopharma reported $51.04M in Equity Capital and Reserves for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Amgen AMGN:US $ 2419M 1503M
Arca Biopharma ABIO:US $ 51.04M 14.87M
Biogen BIIB:US $ 11872.5M 630.2M
Brainstorm Cell Therapeutics BCLI:US $ 7.85M 6.64M
Bristol Myers Squibb BMY:US $ 32600M 1020M
Capricor Therapeutics CAPR:US $ 18.73M 5.91M
Cytokinetics CYTK:US $ 111.41M 4.85M
Cytrx CYTR:US 3.28M 1.5M
Daiichi Sankyo 4568:JP Y 1400252M 49380M
Gilead Sciences GILD:US $ 20215M 288M
GlaxoSmithKline GSK:LN 16374M 193M
Laboratory Of America LH:US $ 10400.7M 320.4M
Myriad Genetics MYGN:US $ 947.4M 2.7M
Otsuka Holdings 4578:JP Y 2225225M 156147M
United Therapeutics UTHR:US $ 4318.4M 142.1M